Source: International Congress 2015 – Treatment and control of respiratory disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Young J Juhn (Rochester, United States of America), Rohit Divekar, Chung Il Wi, Miguel Park, Roshini Abraham, Young Juhn. The relationship between pneumococcal antibody response patterns and asthma status. Eur Respir J 2015; 46: Suppl. 59, 4056

Member's Comments

No comment yet.

Related content which might interest you: Allergen specific immunotherapy: Effect on immunological markers and clinical outcomes in asthmatic children Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016 The role of maternal obesity in susceptibility to respiratory viral infection and exacerbation rate in pregnant women with asthma Source: International Congress 2014 – Asthma: still a heterogeneous condition! Year: 2014 Clinical efficacy of pneumococcal conjugate vaccine in patients with chronic airway disease Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura Year: 2014 Can the influenza vaccine response be predicted in COPD patients by clinical parameters? Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 TH2 specific biomarker profile determines steroid responsiveness in severe asthma Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Clinical features of asthma complicated with eosinophilic otitis media and the effect of treatment with the anti-IgE monoclonal antibody omalizumub Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Biomarkers of asthma severity in the gene environment interaction in respiratory disease (GEIRD) study Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 Antibody responses to rhinovirus and echovirus antigens in children with asthma exacerbations Source: International Congress 2015 – Asthma mechanisms and management Year: 2015 Periostin as a biomarker in patients with asthma: Associations with eosinophilia and Th2 response Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Occupational asthma induced by exposure to high and low molecular weight agents. Similarities and differences Source: Annual Congress 2013 –Occupational respiratory diseases: asthma, silicosis and asbestosis Year: 2013 Relationship between specific rhinitis symptom and control status of asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Overlap phenotypes of asthma in adults: Obesity and atopy Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Comparison of clinical features of severe persistent asthma and refractory asthma Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 Prevalence of refractory asthma in population with severe asthma Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 The potential role of bronchial challenge testing to identify overtreatment of community managed asthma Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 Prevalence of respiratory virus in a selected population of children with asthma exacerbation Source: Annual Congress 2013 –Preschool wheeze Year: 2013 A deficient immune response to viral infections predicts asthma persistence in children Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques Year: 2016 Differences in association between endotoxin and asthma and wheeze with environmental exposures Source: International Congress 2015 – Indoor air and ambient pollution Year: 2015 Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis Source: International Congress 2014 – Intervening in allergic asthma Year: 2014